Otitis Media Clinical Trial
Official title:
An Open-Label Study of Levofloxacin to Evaluate Bacteriologic Outcome in the Treatment of Children Who Are at Risk for Acute Otitis Media That is Difficult to Treat
The purpose of the study is to assess the rate of elimination of bacteria by levofloxacin in middle ear fluid of children with a rapid and severe onset of infection and inflammation of the middle ear who are at high risk for infections that are difficult to treat.
Rapid and severe onset of middle ear infection is a common bacterial infection in children. These infections, particularly when they occur early in life and are recurrent, are associated with considerable disease and can lead to increasingly serious infections. This is a multicenter study to determine the effectiveness of levofloxacin in eliminating bacteria in the middle ear fluid of children between 6 months and 5 years of age with a rapid and severe onset of infection and inflammation of the middle ear (who are at high risk for infections that are difficult to treat). The study consists of a 1-day screening period when patients will be tested for eligibility for the study; a 4 to 6-day treatment, blood collection, possible collection of fluid from the middle ear, and assessment period; and a post-treatment period to assess the status of the middle ear infection. All patients will receive levofloxacin 2 times daily (up to a maximum daily dose of 500 mg) mixed with liquid and taken by mouth for 10 days. Safety evaluations will include laboratory tests, physical examinations, vital sign measurements, and recording of adverse events, including any report of joint pain or signs and symptoms of joint disease. Effectiveness will be assessed by the rate of elimination of the bacteria identified at the start of the study and by signs and symptoms, as well as microscopic evidence that the patient is cured of the middle ear infection. The study hypothesis is that levofloxacin will be effective in eliminating bacteria in the middle ear fluid of children with a rapid and severe onset of infection and inflammation of the middle ear and who are at high risk for infections that are difficult to treat. Levofloxacin 10 milligrams/kilogram (mg/kg) 2 times daily (up to a maximum daily dose of 500 mg) mixed with liquid and taken by mouth for 10 days ;
Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04016051 -
Acceptance of Clarithromycin in a Straw Compared to Syrup in Children With Upper Respiratory Tract Infections
|
Phase 3 | |
Completed |
NCT02452164 -
Family MobilePhone Otoscopy in Diagnostics of Otitis Media
|
N/A | |
Completed |
NCT01199016 -
Effect of Prevnar 13 on Ear Infections in Children
|
Phase 4 | |
Terminated |
NCT00778063 -
Study Using Dexmedetomidine to Decreases Emergence Delirium in Pediatric Patients
|
N/A | |
Completed |
NCT00195611 -
Study of Streptococcus Pneumoniae in Nose and Throats of Infants With Acute Otitis Media
|
Phase 4 | |
Recruiting |
NCT03722160 -
Clinical Study of the Solo Tympanostomy Tube Device
|
N/A | |
Recruiting |
NCT04447521 -
Surveillance of Non-invasive Streptococcus Pneumoniae Infections in Belgium
|
||
Active, not recruiting |
NCT05127161 -
Broad Implementation of Outpatient Stewardship
|
N/A | |
Completed |
NCT02600559 -
Open-Label Study of OTO-201 in Pediatric Subjects With a History of Otitis Media Requiring Tympanostomy Tubes
|
Phase 3 | |
Completed |
NCT01444391 -
inVENT-visIOn Study
|
N/A | |
Enrolling by invitation |
NCT01437436 -
The Effect of Obesity on Ventilation Tube Insertion
|
N/A | |
Completed |
NCT01003210 -
Homeopathic Ear Drops for Otitis Media Study
|
N/A | |
Completed |
NCT00768534 -
Study Evaluating Microbiological Analysis of Spontaneous Draining Acute Otitis Media
|
N/A | |
Recruiting |
NCT00393159 -
The Influence of The Ear Popper on Serous Otitis Media and on the Accompanying Conductive Hearing Loss in Children
|
Phase 4 | |
Completed |
NCT00617682 -
Maternal Immunization To Prevent Infant Otitis Media
|
Phase 1/Phase 2 | |
Withdrawn |
NCT00956748 -
N-Acetylcysteine as an Adjunct for Refractory Chronic Suppurative Otitis Media
|
Phase 4 | |
Withdrawn |
NCT01908764 -
Pharmacokinetic Study of AL-60371 Otic Suspension in Pediatric Subjects Following Tympanostomy Tube Surgery
|
Phase 1 | |
Recruiting |
NCT01619462 -
Safety and Immunogenicity of 10-valent and 13-valent Pneumococcal Conjugate Vaccines in Papua New Guinean Children
|
Phase 3 | |
Completed |
NCT02616458 -
The Impact of Ear Pain Anticipatory Guidance Counseling on Otitis Related Visits in a Low Income Population
|
N/A | |
Completed |
NCT00051753 -
Levofloxacin In The Treatment Of Children With Recurrent And/or Persistent Acute Otitis Media
|
Phase 3 |